Cargando…
An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation
Organ transplantation has always been considered to be the optimal therapeutic intervention in patients with end-stage organ failure. In the US, approximately 615,000 patients are diagnosed with end-stage renal disease and less than 30% have received a kidney transplant. One of the crucial drawbacks...
Autores principales: | Khan, Asif, Nasr, Patricia, El-Charabaty, Elie, El-Sayegh, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817575/ https://www.ncbi.nlm.nih.gov/pubmed/27081421 http://dx.doi.org/10.14740/jocmr2411w |
Ejemplares similares
-
Fungal Infections in Renal Transplant Patients
por: Khan, Asif, et al.
Publicado: (2015) -
Renal infarction in COVID-19 patient
por: Ammous, Ahmad, et al.
Publicado: (2020) -
Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure
por: Modi, Jwalant, et al.
Publicado: (2015) -
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study
por: Saifan, Chadi, et al.
Publicado: (2013) -
Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements
por: Saifan, Chadi, et al.
Publicado: (2013)